Literature DB >> 11091500

Expansion and transduction of nonenriched human cord blood cells using HS-5 conditioned medium and FLT3-L.

M Goerner1, B Roecklein, B Torok-Storb, S Heimfeld, H P Kiem.   

Abstract

Cord blood (CB) stem cell transplantations have been associated with delayed hematopoietic engraftment. This has most likely been due to the limited numbers of hematopoietic short-term repopulating cells in CB. Ex vivo expansion of CB has been attempted, and expansion of CD34-enriched CB has been successful; however, CD34 enrichment procedures are in general associated with substantial cell loss. Thus, we have studied culture conditions for expansion of nonenriched CB. Nonenriched CB cells were cultured for 21 days in the presence of conditioned medium from the HS-5 stromal cell line and FLT3-L or alternatively in the presence of FLT3-L, stem cell factor (SCF), megakaryocite growth and development factor (MGDF), and granulocyte colony-stimulating factor (G-CSF) (FSMG), either on fibronectin fragment CH-296-coated dishes or on uncoated dishes. With all four culture conditions, the number of mononuclear cells initially decreased until day 7 and then increased until the end of the expansion cultures. Overall expansion using HS-5 and FLT3-L resulted in superior expansion of MNC and CFU-C (44-/34-fold) for both cultures with and without CH-296 compared to FSMG (18-/17-fold). Expansion on CH-296 was less efficient than expansion on tissue culture-treated wells without CH-296 for both conditions. We then studied the best time for transduction on nonenriched CB. In contrast to enriched CD34 cells, we found for both conditions, HS-5/FLT3-L and growth factor cocktail, higher transduction efficiencies when cells were transduced on day 7 as compared to day 2. Gene transfer rates up to 45% were achieved with both conditions, which corresponded with the increased number of cells in S phase on day 7 compared to day 2. We conclude that HS-5 and FLT-3L allow efficient expansion and transduction of nonenriched CB.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11091500     DOI: 10.1089/15258160050196803

Source DB:  PubMed          Journal:  J Hematother Stem Cell Res        ISSN: 1525-8165


  4 in total

1.  A preclinical model of double- versus single-unit unrelated cord blood transplantation.

Authors:  George E Georges; Vladimir Lesnikov; Szczepan W Baran; Anna Aragon; Marina Lesnikova; Robert Jordan; Ya-Ju Laura Yang; Murad Y Yunusov; Eustacia Zellmer; Shelly Heimfeld; Gopalakrishnan M Venkataraman; Michael A Harkey; Scott S Graves; Rainer Storb; Barry E Storer; Richard A Nash
Journal:  Biol Blood Marrow Transplant       Date:  2010-03-18       Impact factor: 5.742

2.  No telomere shortening in marrow stroma from patients with MDS.

Authors:  A Mario Marcondes; Steven Bair; Peter S Rabinovitch; Ted Gooley; H Joachim Deeg; Rosana Risques
Journal:  Ann Hematol       Date:  2008-12-03       Impact factor: 3.673

3.  Identification of DJ-1/PARK-7 as a determinant of stroma-dependent and TNF-alpha-induced apoptosis in MDS using mass spectrometry and phosphopeptide analysis.

Authors:  A Mario Marcondes; Xiang Li; Ted A Gooley; Brian Milless; H Joachim Deeg
Journal:  Blood       Date:  2010-01-08       Impact factor: 22.113

4.  Human cytomegalovirus plasmid-based amplicon vector system for gene therapy.

Authors:  Kutubuddin Mahmood; Mark N Prichard; Gregory M Duke; George W Kemble; Richard R Spaete
Journal:  Genet Vaccines Ther       Date:  2005-01-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.